What is BX's health score?

Blackstone Inc. (BX) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BX's estimated fair value?

Based on our 5-year discounted cash flow model, Blackstone Inc.'s estimated fair value is $39.11 per share, representing a -64.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BX undervalued or overvalued?

Our model currently rates BX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BX... Refresh in a moment for the full analysis.

Blackstone Inc. (BX)

Financials Overvalued low mixed

$110.28

Updated: 2026-06-04

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

58 Mixed

Relative Value

45 Mixed

Capital Allocation

30 Weak

Risk

80 Strong

Est. Fair Value $39.11

DCF Upside -64.5%

Sector Rank #4569 of 6348

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.